Published in Am J Psychiatry on November 01, 1988
Zaleplon, A Novel Nonbenzodiazepine Hypnotic, Effectively Treats Insomnia in Elderly Patients Without Causing Rebound Effects. Prim Care Companion J Clin Psychiatry (1999) 1.03
Benzodiazepine use and abuse in Canada. CMAJ (1989) 0.98
Psychological treatment of hypnotic-dependent insomnia in a primarily older adult sample. Behav Res Ther (2013) 0.80
Disturbed sleep in the elderly. Am J Psychiatry (1989) 0.75
Sleep disturbance in cognitively impaired elderly person. Am J Psychiatry (1989) 0.75
Polypharmacy in the Elderly: Drug reactions and interaction in the aged. Can Fam Physician (1991) 0.75
Efficacy of a therapeutic cocaine vaccine in rodent models. Nat Med (1996) 3.11
Urinary prostaglandins. Identification and origin. J Clin Invest (1975) 3.07
The disposition of propranolol. 3. Decreased half-life and volume of distribution as a result of plasma binding in man, monkey, dog and rat. J Pharmacol Exp Ther (1973) 2.54
Elevation of beta-adrenergic receptor density in human lymphocytes after propranolol administration. J Clin Invest (1980) 2.40
Coronary arterial smooth muscle contraction by a substance released from platelets: evidence that it is thromboxane A2. Science (1976) 2.39
Patients' perspectives on the management of emotional distress in primary care settings. J Gen Intern Med (1997) 2.35
Prevalence of broad-host-range lytic bacteriophages of Sphaerotilus natans, Escherichia coli, and Pseudomonas aeruginosa. Appl Environ Microbiol (1998) 2.15
Isolation and preliminary characterization of bacteriophage phi-mu-4. J Bacteriol (1964) 1.99
Comparative assessment of stimuli that release neuronal and adrenomedullary catecholamines in man. Circulation (1979) 1.88
Clinical pharmacology of propranolol. Circulation (1975) 1.79
Severe allopurinol hypersensitivity. Association with thiazides and prior renal compromise. Arch Intern Med (1974) 1.76
Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow. J Clin Invest (1974) 1.74
Contribution of kinins to endotoxin shock in unanesthetized Rhesus monkeys. Circ Res (1968) 1.66
Simultaneous measurement of cardiac output and its distribution with microspheres in the rat. Cardiovasc Res (1976) 1.66
Normal distribution of cardiac output in the unanesthetized, restrined rhesus monkey. J Appl Physiol (1968) 1.65
Evidence that nitric acid increases relative humidity in low-temperature cirrus clouds. Science (2004) 1.63
Simultaneous analysis of dapsone and monoacetyldapsone employing high performance liquid chromatography: a rapid method for determination of acetylator phenotype. Br J Clin Pharmacol (1978) 1.57
Time required for complete recovery from chronic propranolol therapy. N Engl J Med (1973) 1.51
The hemodynamic effects of beta adrenergic blockade on the flow-dependent hepatic clearance of propranolol. J Pharmacol Exp Ther (1973) 1.43
Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome. N Engl J Med (1978) 1.37
Altered hepatic blood flow and drug disposition. Clin Pharmacokinet (1976) 1.34
Sustained hypertension after section of the glossopharyngeal nerve. Am J Med (1977) 1.30
Salicornia bigelovii Torr.: An Oilseed Halophyte for Seawater Irrigation. Science (1991) 1.29
Effect of indomethacin and aspirin on gastric blood flow and acid secretion. J Pharmacol Exp Ther (1977) 1.25
Paper replication method for isolation of radiation-sensitive mutants. Appl Environ Microbiol (1983) 1.23
The hemodynamic effects of prostaglandins in the rat. Evidence for important species variation in renovascular responses. Circ Res (1979) 1.20
Kinins: possible mediators of neonatal circulatory changes in man. J Clin Invest (1968) 1.19
The effects of arachidonic acid, prostaglandin E2 and prostaglandin F2alpha on the longitudinal stomach strip of the rat. J Pharmacol Exp Ther (1973) 1.18
Drug therapy: Psychotropic drug use in the elderly (first of two parts). N Engl J Med (1983) 1.15
Mechanism of increased sodium reabsorption during propranolol administration. Circulation (1971) 1.14
Physiochemical characterization of a neonatal calf diarrhea virus. Can J Comp Med (1973) 1.14
Factors modifying the early nondiuretic vascular effects of furosemide in man. The possible role of renal prostaglandins. Circ Res (1983) 1.14
Light-induced charge separation in anatase TiO2 particles. J Phys Chem B (2005) 1.13
Prostaglandins and renin release: II. Assessment of renin secretion following infusion of PGI2,E2 and D2 into the renal artery of anesthetized dogs. Prostaglandins (1978) 1.11
The reduction of lidocaine clearance by dl-propranolol: an example of hemodynamic drug interaction. J Pharmacol Exp Ther (1973) 1.10
Plasma binding and disposition of furosemide in the nephrotic syndrome and in uremia. Clin Pharmacol Ther (1978) 1.10
Regional hemodynamic effects of beta-adrenergic blockade with propranolol in the unanesthetized primate. Am Heart J (1973) 1.08
Hypertensive response to propranolol in a patient treated with methyldopa--a proposed mechansim. Clin Pharmacol Ther (1973) 1.08
Synthesis of prostaglandins by the rat renal papilla in vitro. Mechanism of stimulation by angiotensin II. Biochim Biophys Acta (1975) 1.06
Trazodone and intrahepatic cholestasis. Ann Intern Med (1983) 1.06
Prostaglandins and renin release: the effect of PGI2, PGE2, and 13,14-dihydro PGE2 on the baroreceptor mechanism of renin release in the dog. Circ Res (1979) 1.06
The effects of a cardioselective (metoprolol) and a nonselective (propranolol) beta-adrenergic blocker on the response to dynamic exercise in normal men. Circulation (1982) 1.06
Strategies for counseling depressed patients by primary care physicians. J Gen Intern Med (1994) 1.06
Suppression of ventricular ectopic depolarizations by tocainide. Circulation (1977) 1.06
Tartrazine and the prostaglandin system. J Allergy Clin Immunol (1979) 1.05
Suppression of chronic ventricular arrhythmias with propranolol. Circulation (1979) 1.04
Enhanced renal prostaglandin production in the dog. II. Effects on intrarenal hemodynamics. Circ Res (1975) 1.04
The prostaglandin system. A role in canine baroreceptor control of renin release. Circ Res (1978) 1.03
Test for carcinogenicity of metallic compounds by the pulmonary tumor response in strain A mice. Cancer Res (1976) 1.03
Endotoxin-induced regional circulatory changes in the unanesthetized monkey. Circ Res (1969) 1.03
Quantifying stratospheric ozone in the upper troposphere with in situ measurements of HCl. Science (2004) 1.03
Underrecognition of patients' psychosocial distress in a university hospital medical clinic. Am J Psychiatry (1983) 1.01
Organophosphate poisoning from wearing a laundered uniform previously contaminated with parathion. JAMA (1989) 1.00
Mechanism of adriamycin cardiotoxicity: evidence for oxidative stress. Life Sci (1981) 0.99
Enhanced renal prostaglandin production in the dog. I. Effects on renal function. Circ Res (1975) 0.98
Release of vasodilator prostaglandin, PGI2, from isolated rat lung during vasoconstriction. Circ Res (1981) 0.97
The disposition of propranolol. 8. General implications of the effects of liver blood flow on elimination from the perfused rat liver. Drug Metab Dispos (1974) 0.96
Carbon isotope discrimination and bundle sheath leakiness in three C(4) subtypes grown under variable nitrogen, water and atmospheric CO(2) supply. J Exp Bot (2002) 0.95
Interaction of quinidine with anticonvulsant drugs. N Engl J Med (1976) 0.95
Inhibition of acid secretion in isolated canine parietal cells by prostaglandins. J Pharmacol Exp Ther (1982) 0.95
Hemodynamic drug interactions: the reduction of oxyphenbutazone clearance by dl-propranol in the dog. J Pharmacol Exp Ther (1973) 0.94
Effects of pindolol and propranolol on beta-adrenergic receptors on human lymphocytes. Br J Clin Pharmacol (1982) 0.94
The critical times: meeting parental communication needs throughout the NICU experience. Neonatal Netw (1993) 0.93
Control of canine renin release: macula densa requires prostaglandin synthesis. J Physiol (1981) 0.93
Prostacyclin produced by the pregnant uterus in the dog may act as a circulating vasodepressor substance. J Clin Invest (1981) 0.93
The detection of large HNO3-containing particles in the winter Arctic stratosphere. Science (2001) 0.92
Influence of hypertonic saline on canine renal blood flow and renin release. Am J Physiol (1979) 0.92
Lethal action of ribonuclease for thermophilic bacilli. J Bacteriol (1966) 0.91
Interrelationship between prostaglandins and renin release. Kidney Int (1981) 0.90
Indomethacin-furosemide interaction: the importance of renal blood flow. J Pharmacol Exp Ther (1983) 0.90
Minoxidil in severe hypertension: value when conventional drugs have failed. Am Heart J (1975) 0.90
Controlled lysis of bacterial cells utilizing mutants with defective synthesis of D-alanine. Can J Microbiol (1988) 0.90
Effects of alteration of hepatic microsomal enzyme activity on liver blood flow in the rat. Biochem Pharmacol (1976) 0.90
Changing relationships between testis size, Sertoli cell number and spermatogenesis in Sprague-Dawley rats. J Androl (1991) 0.90
Antiarrhythmic effects of a lidocaine congener, tocainide, 2-amino-2',6'-propionoxylidide, in man. Clin Pharmacol Ther (1976) 0.89
Drugs five years later: dextran 40. Ann Intern Med (1974) 0.89
Bradykinin production associated with oxygenation of the fetal lamb. Circ Res (1969) 0.89
Alteration of canine renal vascular response to hemorrhage by inhibitors of prostaglandin synthesis. Am J Physiol (1976) 0.89
Prostaglandins and the control of the circulation. Clin Pharmacol Ther (1986) 0.89
Sulindac is not renal sparing in man. Clin Pharmacol Ther (1985) 0.88
The influence of indomethacin on the pharmacokinetics, diuretic response and hemodynamics of furosemide in the dog. J Pharmacol Exp Ther (1978) 0.88
Prostaglandins and the regulation of renal circulation and function. Adv Prostaglandin Thromboxane Leukot Res (1982) 0.88
Renal vasoconstrictor response to hypertonic saline in the dog: effects of prostaglandins, indomethacin and theophylline. J Physiol (1986) 0.88
Isolation and characterization of a bacteriophage specific for Sphaerotilus natans which contain an unusual base in its deoxyribonucleic acid. Appl Environ Microbiol (1979) 0.88
Pheochromocytoma: present diagnosis and management. Ann Surg (1976) 0.88
Decreased beta adrenergic receptor density on human lymphocytes after chronic treatment with agonists. J Pharmacol Exp Ther (1983) 0.88
Nongenomic actions of estrogen in the brain: physiological significance and cellular mechanisms. Crit Rev Neurobiol (1996) 0.88
Age and gender influence the stereoselective pharmacokinetics of propranolol. J Pharmacol Exp Ther (1992) 0.88
A double-blind, randomized, controlled trial comparing pinacidil to hydralazine in essential hypertension. Clin Pharmacol Ther (1987) 0.88
Cerebral arterial smooth muscle contraction by thromboxane A2. Stroke (1977) 0.87
Variant angina pectoris: investigation of indexes of sympathetic nervous system function. Am J Cardiol (1979) 0.87
Furosemide-induced vasodilation: importance of the state of hydration and filtration. Kidney Int (1980) 0.87
Taking care of culturally different and non-English speaking patients. Int J Psychiatry Med (1990) 0.87
Stereospecific interaction of tocainide with the cardiac sodium channel. Mol Pharmacol (1988) 0.87
UV light-induced survival response in a highly radiation-resistant isolate of the Moraxella-Acinetobacter group. Appl Environ Microbiol (1982) 0.87
Hemodynamic effects of platelet activating factor in the dog kidney in vivo. Hypertension (1986) 0.86
Abrupt withdrawal of cardiovascular drugs. N Engl J Med (1979) 0.86
Clinical pharmacology of antihypertensive drugs. Med Clin North Am (1977) 0.86
The relationship of plasma guanethidine levels to adrenergic blockade. Clin Pharmacol Ther (1975) 0.86